The growth in the biosimilar market since 2006 has been significant. Biosimilars have no meaningful clinical differences between the originator medicine in terms of safety and efficacy and are typically less expensive than the originator. These factors lead to the popularity of biosimilars to help bring safe and effective drugs to market at an affordable price What are biosimilars and biological medicines? A biosimilar medicine is a type of biological medicine that is develo